Evaluation of a Simple and Accurate Method for Intraocular Lens Constant Optimization Using Linear Interpolation
Sumitaka Miyamoto1, Kazutaka Kamiya2
1Aira Miyamoto Eye Clinic, Aira 8995213, Japan.
Abstract:
Objectives: We devised a simple and practical method for optimizing intraocular lens (IOL) constants using linear interpolation, based on the IOL power calculation study protocol proposed by Hoffer et al., and evaluated its effectiveness. Methods: This retrospective study included 188 eyes from 188 Japanese patients who underwent cataract surgery with the implantation of CNA0T0 (Alcon) between June 2022 and September 2024. Preoperative biometric data were obtained using ARGOS (Alcon) and OA-2000 (Tomey). Predicted refractions were calculated using the European Society of Cataract and Refractive Surgeons' (ESCRS) IOL Web Calculator with the EVO, Hill-RBF 3.0 (Hill), and Kane formulas, using both A-constants of 119.1 and 119.33. The mean prediction error (MPE) was calculated as the difference between the predicted and postoperative spherical equivalent at 3 months. Linear interpolation was applied to the paired results to derive optimized A-constants yielding MPE = 0 and to correct each case's predicted refraction values ("corrected values"). Additionally, predicted refractions were recalculated using the optimized A-constants with the ESCRS IOL Web Calculator to obtain "actual values". Both corrected and actual values achieved an MPE of 0 and were compared using the Friedman test and Cochran's Q test. Results: The optimized A-constants for ARGOS were 119.540 (EVO), 119.733 (Hill), and 119.563 (Kane); for OA-2000, they were 119.388, 119.532, and 119.417, respectively. No significant differences were found between corrected and actual values under any condition. Conclusions: This method is simple, accurate, and applicable to new IOLs, devices, and formulas, with potential to improve the precision of clinical IOL power calculations.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Focusing of Light in the Eye


